Amy Emerson
Impact in
- Toxicology top 1%
- Forensic Toxicology and Drug Analysis
- Clinical Psychology top 2%
- Psychedelics and Drug Studies
- Posttraumatic Stress Disorder Research
Papers in
- Pharmacology 16
- Cannabis and Cannabinoid Research 15
- Treatment of Major Depression 4
-
- Psychedelics and Drug Studies 14
- Posttraumatic Stress Disorder Research 3
- Psychotherapy Techniques and Applications 2
- Co-authors
- Berra Yazar‐KlosinskiLisa JeromeRick DoblinAllison A. FeducciaMichael C. MithoeferScott HamiltonAnn T. MithoeferJulie B. Wang
- Journals
- Frontiers in Psychiatry (2 papers)Journal of Humanistic Psychology (2 papers)Journal of Psychopharmacology (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Amy Emerson
23 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Toxicology 184
- Clinical Psychology 986
- Biological Psychiatry 75
- Cellular and Molecular Neuroscience 411
- Pharmacology 368
Countries citing papers authored by Amy Emerson
This map shows the geographic impact of Amy Emerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Emerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Emerson more than expected).
Fields of papers citing papers by Amy Emerson
This network shows the impact of papers produced by Amy Emerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Emerson. The network helps show where Amy Emerson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Emerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 21 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 40 | |
| 8 | 2022 | 42 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 58 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 88 | |
| 14 | 2020 | 47 | |
| 15 | 2019 | 108 | |
| 16 | 2018 | 161 | |
| 17 | 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial Hit paper breakdown → | 2018 | 272 |
| 18 | 2018 | 155 | |
| 19 | 2014 | 33 | |
| 20 | 2010 | 7 |
About Amy Emerson
Amy Emerson is a scholar working on Pharmacology, Clinical Psychology, Biological Psychiatry, Toxicology and Cognitive Neuroscience, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (15 papers), Psychedelics and Drug Studies (14 papers), Treatment of Major Depression (4 papers), Posttraumatic Stress Disorder Research (3 papers), Cardiac Arrhythmias and Treatments (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Cardiac pacing and defibrillation studies (2 papers) and Psychotherapy Techniques and Applications (2 papers). The work is most often cited by research in Toxicology (184 citations), Clinical Psychology (986 citations), Biological Psychiatry (75 citations), Cellular and Molecular Neuroscience (411 citations) and Pharmacology (368 citations). Amy Emerson has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Berra Yazar‐Klosinski, Lisa Jerome, Rick Doblin, Allison A. Feduccia, Michael C. Mithoefer, Scott Hamilton, Ann T. Mithoefer, Julie B. Wang, Julie Holland and Mark T. Wagner. Their work appears in journals such as Frontiers in Psychiatry, Journal of Humanistic Psychology, Journal of Psychopharmacology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.